Jeff Del Carmen

Jeff Del Carmen joined Catalyst in August 2018 as Senior Vice President of Sales and Marketing and was promoted to Chief Commercial Officer in June 2020. Mr. Del Carmen brings over 22 years of pharmaceutical experience to Catalyst, including numerous commercial leadership positions in the neurology orphan disease space. Most recently, Mr. Del Carmen served as VP of Business Development at Paragon Biosciences where he focused on business development for orphan neurology diseases. Prior to joining Paragon, he was Senior Director-Rare Disease Marketing at Marathon Pharmaceuticals. Previously, Mr. Del Carmen served as VP of Sales at Insys Therapeutics from January 2016 to July 2016, as well as National Sales Director of Movement Disorders and Regional Business Director of Neurology at Lundbeck. He also held numerous sales and marketing positions of increasing responsibility at Abbott Laboratories. Mr. Del Carmen holds a B.A. in Economics from the University of Dayton and an Executive MBA from the University of Wisconsin-Madison.